Biohit Oyj’s President and CEO Semi Korpela to leave the company

Report this content

Stock exchange release

Biohit Oyj 17.5.2021 at 06.30 pm local time (EEST)


Biohit Oyj’s Board of Directors has decided that Semi Korpela will immediately leave the company as the President and CEO. The Board of Directors will commence a recruitment process for a new CEO and Biohit’s Chairman of the Board Osmo Suovaniemi will continue as deputy CEO.

The Board of Directors of Biohit thanks Semi Korpela for the almost 10-year period at the company.


Biohit Oyj

Board of Directors


Further information:

Osmo Suovaniemi, Chairman of the Board of Directors, +358 9 773 861



Nasdaq Helsinki Ltd.

Major media


Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is "Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the United Kingdom. Biohit’s series B share (BIOBV) is quoted on NASDAQ OMX Helsinki, Small cap/Healthcare.